Medicus Pharma Ltd. (MDCX)

Medicus Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	9.67	4.16	1.72	0.27	0.08
Cash & Short-Term Investments	9.67	4.16	1.72	0.27	0.08
Cash Growth	228.99%	142.21%	542.38%	240.90%	-
Prepaid Expenses	0.95	1.21	0.17	0.02	-
Total Current Assets	11	5.38	1.89	0.28	0.08
Property, Plant & Equipment	0.22	0.27	-	-	-
Total Assets	11.93	5.65	1.89	0.28	0.08
Accounts Payable	1.77	1.28	0.21	0.1	0.16
Accrued Expenses	1.95	0.76	0.4	-	-
Short-Term Debt	4.7	0.14	0.17	1.53	0.67
Current Portion of Leases	0.12	0.12	-	-	-
Other Current Liabilities	-	-	-	10.85	9.75
Total Current Liabilities	8.54	2.31	0.78	12.48	10.58
Long-Term Leases	0.14	0.21	-	-	-
Total Liabilities	8.69	2.51	0.78	12.48	10.58
Common Stock	37.83	30.52	18.76	0.19	0.19
Additional Paid-In Capital	5.6	1.52	0.1	-	-
Retained Earnings	-40.18	-28.9	-17.75	-12.39	-10.7
Shareholders' Equity	3.25	3.13	1.11	-12.2	-10.51
Total Liabilities & Equity	11.93	5.65	1.89	0.28	0.08
Total Debt	4.97	0.46	0.17	1.53	0.67
Net Cash (Debt)	4.7	3.7	1.55	-1.26	-0.59
Net Cash Growth	83.43%	138.16%	-	-	-
Net Cash Per Share	0.38	0.38	0.45	-0.67	-0.18
Filing Date Shares Outstanding	15.94	11.82	8.08	6.43	3.22
Total Common Shares Outstanding	15.94	11.82	8.08	6.43	3.22
Working Capital	2.45	3.07	1.11	-12.2	-10.51
Book Value Per Share	0.20	0.27	0.14	-1.90	-3.27
Tangible Book Value	3.25	3.13	1.11	-12.2	-10.51
Tangible Book Value Per Share	0.20	0.27	0.14	-1.90	-3.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q